Efficacy and neurologic outcome of profound hypocapneic alkalosis for the treatment of persistent pulmonary hypertension in infancy
- 1 September 1984
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 105 (3) , 457-461
- https://doi.org/10.1016/s0022-3476(84)80029-3
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- The independent effects of hyperventilation, tolazoline, and dopamine on infants with persistent pulmonary hypertensionThe Journal of Pediatrics, 1981
- Changes in cerebral blood flow during hyperventilation and CO2‐breathing measured transcutaneously in humans by a bidirectional, pulsed, ultrasound doppler blood velocitymeterActa Physiologica Scandinavica, 1980
- Refractory hypoxemia associated with neonatal pulmonary disease: The use and limitations of tolazolineThe Journal of Pediatrics, 1979
- Physiologic factors affecting pulmonary artery pressure in infants with persistent pulmonary hypertensionThe Journal of Pediatrics, 1978
- The Clinical Profile of the Newborn with Persistent Pulmonary HypertensionClinical Pediatrics, 1977
- Persistent pulmonary hypertension of the newborn infantThe Journal of Pediatrics, 1976
- Neonatal hypoxia and pulmonary vasospasm: Response to tolazolineThe Journal of Pediatrics, 1976
- Arterial Pco2 and cerebral hemodynamicsAmerican Journal of Physiology-Legacy Content, 1964
- THE EFFECTS OF ACTIVE AND PASSIVE HYPERVENTILATION ON CEREBRAL BLOOD FLOW, CEREBRAL OXYGEN CONSUMPTION, CARDIAC OUTPUT, AND BLOOD PRESSURE OF NORMAL YOUNG MEN 1Journal of Clinical Investigation, 1946
- CEREBRAL CIRCULATIONArchives of Neurology & Psychiatry, 1930